18F-FDG PET/CT在肾上腺皮质肿瘤显像中优于68Ga-FAPI PET/CT
Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging.
PubMed 文献 · Clin Nucl Med · 2023-02-08
本文报告一例62岁女性肾上腺皮质癌术后患者,为评估治疗反应行18F-FDG PET/CT,左肾上腺区复发灶及转移灶均见FDG高摄取;68Ga-FAPI-04 PET/CT中复发灶及转移灶FAPI摄取均低。作者据此认为18F-FDG PET/CT在肾上腺皮质癌评估中优于68Ga-FAPI-04 PET/CT。
要点
- 62岁女性肾上腺皮质癌术后患者,为评估治疗反应行18F-FDG PET/CT。
- 18F-FDG PET/CT示左肾上腺区复发灶及转移灶FDG高摄取。
- 68Ga-FAPI-04 PET/CT示复发灶及转移灶FAPI摄取均低。
核心结论
- 作者认为,在本例中18F-FDG PET/CT在肾上腺皮质癌评估中优于68Ga-FAPI-04 PET/CT。
研究设计与样本
- 本文为病例报告,对象为1例62岁女性肾上腺皮质癌术后患者,为评估治疗反应行18F-FDG PET/CT与68Ga-FAPI-04 PET/CT。
主要发现
- 18F-FDG PET/CT示左肾上腺区复发灶及转移灶FDG高摄取。
- 68Ga-FAPI-04 PET/CT示复发灶及转移灶FAPI摄取均低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
18 F-FDG PET/CT was performed to evaluate the response to treatment in a 62-year-old female patient who was operated for adrenocortical carcinoma. High FDG uptake was observed in recurrent lesion in the left adrenal gland site and metastatic lesions. In the 68 Ga-FAPI-04 PET/CT study, low FAPI uptake was observed in both recurrences and metastases. In this case, we demonstrated the superiority of 18 F-FDG PET/CT over 68 Ga-FAPI-04 PET/CT in the evaluation of adrenocortical carcinoma.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Kaplan İ, Can C, Kepenek F, et al. Superiority of 18 F-FDG PET/CT to 68 GA-FAPI PET/CT in Adrenocortical Tumor Imaging. Clin Nucl Med. 2023. PMID: 36754357. doi:10.1097/RLU.0000000000004601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。